BioGaia
Prodentis
Choose this if you want the clinically studied strains at known doses.
Uses L. reuteri DSM 17938 + ATCC PTA 5289 — the exact strains with published dental RCTs — at transparent, verified doses.
PRODENTIM
ProDentim packages three probiotic strains with modest individual evidence into a proprietary blend at a premium price — without ever testing the finished formula in a clinical trial. The L. reuteri evidence for gum health is real but narrow, and effects reverse when you stop taking it. At $2.30 per tablet, this is an expensive bet on unproven oral probiotic science when basic dental hygiene delivers more reliable results for free.
Our verdict
ProDentim packages three probiotic strains with modest individual evidence into a proprietary blend at a premium price — without ever testing the finished formula in a clinical trial. The L. reuteri evidence for gum health is real but narrow, and effects reverse when you stop taking it. At $2.30 per tablet, this is an expensive bet on unproven oral probiotic science when basic dental hygiene delivers more reliable results for free.
Scored against the Fitlab Scoring Protocol — five weighted pillars totalling 100%.
Contains three probiotic strains — L. reuteri, L. paracasei, and B. lactis BL-04 — at a combined 3.5 billion CFU. L. reuteri has the strongest oral-health evidence: a handful of RCTs show modest reductions in gum bleeding when used as an adjunct to professional dental cleaning (Tekce et al., 2015; Iniesta et al., 2012). However, effects were temporary and reversed upon discontinuation. L. paracasei has limited direct oral evidence. B. lactis BL-04 is primarily studied for immune and respiratory outcomes, not oral health. The supporting ingredients — inulin (prebiotic fibre), malic acid (claimed for whitening), tricalcium phosphate (remineralisation), and peppermint — have either indirect or negligible evidence for the claimed benefits at supplement doses. No clinical trial has ever tested ProDentim as a finished formula.
ProDentim uses a proprietary blend structure. While the total CFU count (3.5 billion) is stated, the per-strain CFU breakdown is not disclosed. This means consumers cannot compare the dose of L. reuteri in ProDentim to the doses used in clinical studies (typically 2×10⁸ CFU of L. reuteri DSM 17938 per lozenge in published trials). The four supporting ingredients are also bundled without individual dosages. For a product priced at $69 per bottle, this level of opacity is below category standards set by brands like Seed, which disclose per-strain CFU and publish third-party assays.
No third-party testing certifications are prominently displayed (no NSF, USP, Informed Sport, or ConsumerLab seal). No published COA (Certificate of Analysis) for batch-level probiotic viability — a critical metric since probiotics lose potency over shelf life. The product is sold exclusively through its own website via ClickBank, bypassing retail quality gatekeepers (Amazon FBA, Walmart, etc. typically require documentation). The FDA disclaimer on the website is standard for supplements, but the absence of any independent verification is a significant gap at this price point.
Single bottle: $69 for 30 tablets ($2.30/tablet). Three-pack: $177 ($1.97/tablet). Six-pack: $294 ($1.63/tablet). For comparison, a clinically studied oral probiotic like BioGaia Prodentis (L. reuteri DSM 17938 + ATCC PTA 5289, the actual strains with published dental RCTs) retails for approximately $25–30 for 30 lozenges ($0.83–1.00/day). ProDentim charges 2–3× more than the brand with the actual clinical data. The 60-day money-back guarantee partially offsets the price risk, but the value proposition is weak given the evidence gaps.
One soft tablet daily, taken after brushing. Pleasant mint flavour. No refrigeration required (though shelf-stable probiotic viability should be independently verified). Easy to incorporate into existing oral hygiene routine. The chewable/dissolvable format is appropriate for an oral probiotic — it allows the bacteria to colonise the oral cavity directly rather than being swallowed. This is one area where ProDentim's delivery mechanism is well-designed.
ProDentim is a chewable oral probiotic tablet containing 3.5 billion colony-forming units (CFU) from three bacterial strains: Lactobacillus reuteri, Lactobacillus paracasei, and Bifidobacterium lactis BL-04. Four supporting ingredients round out the formula — inulin (a prebiotic fibre), malic acid, tricalcium phosphate, and peppermint. You take one tablet daily, ideally after brushing, letting it dissolve in your mouth so the bacteria can colonise the oral cavity.
The concept behind oral probiotics is legitimate — your mouth is a microbiome, and the bacterial composition of oral flora does influence gum health, breath quality, and cavity risk. Research into oral probiotic interventions has grown substantially over the past decade. The question is not whether oral probiotics are a valid concept. The question is whether ProDentim specifically delivers enough of the right strains at the right doses to produce a meaningful clinical effect. On that question, the evidence is thin.
Lactobacillus reuteri is ProDentim's strongest card, and the evidence is genuinely worth examining. Tekce et al. (2015) published a randomised controlled trial showing that L. reuteri lozenges, used as an adjunct to scaling and root planing (professional dental cleaning), produced modest improvements in gingival bleeding and probing depth compared to placebo. Iniesta et al. (2012) found similar adjunctive benefits for subgingival microbiota composition. These are real studies in real journals.
However, three critical caveats apply. First, these studies used specific L. reuteri strains (DSM 17938 and ATCC PTA 5289) at known doses — ProDentim does not confirm which L. reuteri strain it contains or at what CFU count. Second, the clinical improvements were modest and adjunctive — probiotics enhanced professional cleaning, they did not replace it. Third, and most importantly, benefits reversed when supplementation stopped. The bacteria do not permanently colonise your mouth. You are renting the effect, not buying it.
ProDentim states 3.5 billion total CFU across three strains but does not disclose the per-strain breakdown. This is a fundamental transparency failure. If L. reuteri is present at 100 million CFU and B. lactis BL-04 dominates at 3 billion CFU, the formula's dental evidence base collapses — because B. lactis BL-04 is primarily studied for respiratory and immune outcomes (West et al., 2014), not oral health. Without per-strain disclosure, the consumer is buying a black box.
Compare this to BioGaia Prodentis, which discloses exact strains (L. reuteri DSM 17938 + ATCC PTA 5289) and CFU counts, and has published clinical trials of the finished product — not just individual ingredients. BioGaia costs $25–30 for 30 lozenges. ProDentim costs $69 for 30 tablets. The more expensive product has less transparency and fewer clinical credentials. That pricing inversion tells you most of what you need to know about where your money is going.
ProDentim's marketing claims include 'rejuvenate your gums,' 'cement your teeth,' 'eliminate bad breath,' and 'brighten your smile.' These claims dramatically overstate the clinical evidence. No published study has shown any oral probiotic can 'cement' teeth or 'rejuvenate' gums — these are not medical terms with defined outcomes. The bad breath evidence (Yoon et al., 2022 systematic review) shows that probiotics may temporarily reduce volatile sulphur compounds, but 'eliminate' is not supported. The whitening claim via malic acid rests on topical dental product studies, not on a dissolved tablet at trace doses.
The product's broader claims — respiratory health, allergy support, digestive wellness, even weight loss — leverage the individual ingredient evidence of B. lactis BL-04 and inulin far beyond what the format and dosing in ProDentim can reasonably deliver. A chewable dental tablet is not optimised for gut delivery. These claims function as marketing breadth, not scientific depth.
If you already have excellent dental hygiene — brushing twice daily, flossing, regular dental visits — and want to experiment with an adjunctive oral probiotic, ProDentim is unlikely to cause harm. The probiotic strains are well-characterised and safe. You may notice fresher breath or modest subjective improvements in gum comfort. But the same experiment can be run at lower cost with BioGaia Prodentis, which uses the clinically studied strains at known doses.
If you are considering ProDentim as a solution for existing gum disease, cavities, or chronic halitosis — see a dentist. No oral probiotic is a treatment for established dental pathology. The clinical evidence positions oral probiotics as modest adjuncts to professional care, not replacements for it. Spending $69 on ProDentim instead of a dental cleaning is the wrong allocation of resources.
What we liked
Worth noting
BioGaia
Choose this if you want the clinically studied strains at known doses.
Uses L. reuteri DSM 17938 + ATCC PTA 5289 — the exact strains with published dental RCTs — at transparent, verified doses.
Seed
Choose this if you want a premium probiotic with full transparency and third-party verification.
24 clinically studied strains, transparent per-strain CFU, third-party tested, published human trials of the finished product.
ProDentim packages three probiotic strains with modest individual evidence into a proprietary blend at a premium price — without ever testing the finished formula in a clinical trial. The L. reuteri evidence for gum health is real but narrow, and effects reverse when you stop taking it. At $2.30 per tablet, this is an expensive bet on unproven oral probiotic science when basic dental hygiene delivers more reliable results for free.
LAST REVIEWED ON JUN 24, 2026
Fitlabreviews has strict sourcing guidelines and relies on peer-reviewed studies, academic research, and clinical evidence. Read our editorial policy →